Parametric imaging and test-retest variability of11C-(+)-PHNO binding to D2/D3 dopamine receptors in humans on the high-resolution research tomograph PET scanner

Journal of Nuclear Medicine

Volumn 55, Issue 6, 2014, Pages 960-966

  Gallezot, Jean Dominique ^a   Zheng, Ming Qiang ^a   Lim, Keunpoong ^a   Lin, Shu Fei ^a   Labaree, David ^a   Matuskey, David ^a   Huang, Yiyun ^a   Ding, Yu Shin ^a,b   Carson, Richard E ^a   Malison, Robert T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist; Dopamine D2 receptor; Dopamine D3 receptor; Positron emission tomography; Test retest study

Indexed keywords

CARBON NAXAGOLIDE C 11; CONTRAST MEDIUM; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; TRACER; UNCLASSIFIED DRUG; NAXAGOLIDE; OXAZINE DERIVATIVE; PROTEIN BINDING;

ADULT; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; HYPOTHALAMUS; IMAGE QUALITY; MALE; MOLECULAR IMAGING; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SUBSTANTIA NIGRA; TEST RETEST RELIABILITY; THALAMUS; CLINICAL TRIAL; DEVICES; KINETICS; METABOLISM; REPRODUCIBILITY;

ADULT; FEMALE; HUMANS; KINETICS; MALE; OXAZINES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REPRODUCIBILITY OF RESULTS;

EID: 84903202077     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.132928     Document Type: Article

References (22)

1. 11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4] oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. J Med Chem. 2005;48:4153-4160.
2. Willeit M, Ginovart N, Kapur S, et al. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO. Biol Psychiatry. 2006;59:389-394. (Pubitemid 43289216)
3. 11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse. 2006;60:485-495.
4. Freedman SB, Patel S, Marwood R, et al. Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther. 1994;268:417-426. (Pubitemid 24039117)
5. 11C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse. 2012;66:489-500.
6. 11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage. 2011;54:264-277.
7. 11C](+)-PHNO positron emission tomography (PET). Int J Neuropsychopharmacol. 2010;13:289-290.
8. 11C]-(+)-PHNO binding in the human brain. J Cereb Blood Flow Metab. 2007;27:857-871.
9. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539. (Pubitemid 47301451)
10. 11C]-(+)-PHNO. Neuropsychopharmacology. 2011;36:887-895.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed. Washington, D.C.: American Psychiatric Association; 1994.
12. Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271-1281.
13. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158.
14. Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab. 2002;22:1440-1452. (Pubitemid 35424928)
15. 11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology. 2008;33:279-289.
16. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-428.
17. 11C]-(+)-PHNO human competition studies. Neuroimage. 2013;68:119-132.
18. 11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm. Mol Imaging. 2013;12:77-82.
19. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994;14:995-1010.
20. 11C]raclopride with high-resolution positron emission tomography. J Cereb Blood Flow Metab. 2011;31:155-165.
21. 11C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies. Synapse. 2009;63:574-584.
22. 11C] raclopride. Eur J Nucl Med Mol Imaging. 2013;40:574-579.